Ruchika Talwar

Ruchika Talwar practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Ruchika Talwar's NPI, 1003349440, was assigned on April 4, 2017. Ruchika Talwar graduated from Rutgers New Jersey Medical School in 2017. Ruchika Talwar holds Tennessee license 65446.

Ruchika Talwar's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Ruchika Talwar's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Ruchika Talwar is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Ruchika Talwar to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ruchika Talwar practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Ruchika Talwar's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Ruchika Talwar's licenses on file in 2 states: Tennessee and Pennsylvania.

CMS data shows 126 Medicare services from Ruchika Talwar across 6 procedure codes in 2024, for 98 Medicare patients. Medicare paid $7,687 for them.

CMS counts 98 Medicare patients who saw Ruchika Talwar in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ruchika Talwar's median patient age at 72, with 35% women.

In 2024, Ruchika Talwar wrote 46 Medicare Part D claims for 18 patients. 91% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $229 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

Ruchika Talwar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ruchika Talwar as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Ruchika Talwar, published from 2024 to 2025. 2025 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms. Ruchika Talwar has published most often in Urology. Ruchika Talwar's most frequent co-authors are Marc Andrew Bjurlin, DO, Vishnukamal Golla and Thomas Joseph Guzzo, MD.

CMS Open Payments shows 76 general payments to Ruchika Talwar from 17 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 62% of the total. Urogen Pharma, Inc. paid the most, $3,005.

Ruchika Talwar graduated from Rutgers New Jersey Medical School in 2017.